Repositioning Radiation Oncology at the centre of integrated oncology care: A manifesto of the European Society for Radiotherapy and Oncology (ESTRO)

IF 4.9 1区医学 Q1 ONCOLOGY

Radiotherapy and Oncology Pub Date : 2025-07-12 DOI:10.1016/j.radonc.2025.111035

Icro Meattini , Marianne C. Aznar , Luca Boldrini , Kerstin Borgmann , Catharine H. Clark , Corinne Faivre-Finn , Elizabeth Forde , Uulke A. van der Heide , Barbara Alicja Jereczek-Fossa , Núria Jornet , Anna M. Kirby , Piet Ost , Ivica Ratosa , Kari Tanderup , Esther G.C. Troost , Alessandro J. Cortese , Matthias Guckenberger

{"title":"Repositioning Radiation Oncology at the centre of integrated oncology care: A manifesto of the European Society for Radiotherapy and Oncology (ESTRO)","authors":"Icro Meattini , Marianne C. Aznar , Luca Boldrini , Kerstin Borgmann , Catharine H. Clark , Corinne Faivre-Finn , Elizabeth Forde , Uulke A. van der Heide , Barbara Alicja Jereczek-Fossa , Núria Jornet , Anna M. Kirby , Piet Ost , Ivica Ratosa , Kari Tanderup , Esther G.C. Troost , Alessandro J. Cortese , Matthias Guckenberger","doi":"10.1016/j.radonc.2025.111035","DOIUrl":null,"url":null,"abstract":"<div><div>Modern oncology increasingly relies on integrated, multimodality care, yet radiation oncology remains undervalued in strategic frameworks despite its central therapeutic role. This ESTRO manifesto calls for a repositioning of radiation oncology as a core discipline in cancer care, scientifically, clinically, and politically. The field now extends beyond beam delivery to encompass systemic therapy integration, personalised strategies based on biology and imaging, and active participation in clinical decision-making and guideline development. Radiation oncology contributes to treatment sequencing, synergistic combinations, and innovation in areas such as radioligand therapy and artificial intelligence. ESTRO’s initiatives, including education, research networks, and oncopolicy engagement, underscore the discipline’s broad scope and societal value. Strategic partnerships with Pharma and MedTech, alongside a renewed emphasis on equitable access, are essential to sustaining progress. ESTRO invites all stakeholders to recognise radiation oncology as fundamental to the design, delivery, and evolution of modern cancer therapy.</div></div>","PeriodicalId":21041,"journal":{"name":"Radiotherapy and Oncology","volume":"210 ","pages":"Article 111035"},"PeriodicalIF":4.9000,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiotherapy and Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167814025045396","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Modern oncology increasingly relies on integrated, multimodality care, yet radiation oncology remains undervalued in strategic frameworks despite its central therapeutic role. This ESTRO manifesto calls for a repositioning of radiation oncology as a core discipline in cancer care, scientifically, clinically, and politically. The field now extends beyond beam delivery to encompass systemic therapy integration, personalised strategies based on biology and imaging, and active participation in clinical decision-making and guideline development. Radiation oncology contributes to treatment sequencing, synergistic combinations, and innovation in areas such as radioligand therapy and artificial intelligence. ESTRO’s initiatives, including education, research networks, and oncopolicy engagement, underscore the discipline’s broad scope and societal value. Strategic partnerships with Pharma and MedTech, alongside a renewed emphasis on equitable access, are essential to sustaining progress. ESTRO invites all stakeholders to recognise radiation oncology as fundamental to the design, delivery, and evolution of modern cancer therapy.

查看原文本刊更多论文

重新定位放射肿瘤学在综合肿瘤治疗的中心：欧洲放射与肿瘤学会（ESTRO）的宣言

现代肿瘤学越来越依赖于综合的、多模式的护理，然而放射肿瘤学在战略框架中仍然被低估，尽管它具有中心治疗作用。这份ESTRO宣言呼吁将放射肿瘤学重新定位为癌症治疗的核心学科，无论是科学的、临床的还是政治的。该领域现在已经超越了光束输送，包括系统治疗整合，基于生物学和影像学的个性化策略，以及积极参与临床决策和指南制定。放射肿瘤学有助于治疗测序、协同组合以及放射配体治疗和人工智能等领域的创新。ESTRO的倡议，包括教育、研究网络和政策参与，强调了该学科的广泛范围和社会价值。与制药和医疗技术的战略伙伴关系，以及重新强调公平获取，对于维持进展至关重要。ESTRO邀请所有利益相关者认识到放射肿瘤学是现代癌症治疗设计，交付和发展的基础。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Radiotherapy and Oncology 医学-核医学

CiteScore

10.30

自引率

10.50%

发文量

2445

审稿时长

45 days

期刊介绍： Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.